B
BioVentrix
BioVentrix • Less Invasive Ventricular Enhancement.
About BioVentrix
BioVentrix, Inc. is a privately held medical device company based in San Ramon, CA, specializing in developing innovative treatment options for patients suffering from heart failure. The company operates in the medical technology market, focusing on providing minimally invasive solutions to improve patient outcomes and reduce recovery times. BioVentrix's core product, the Revivent System, is designed to treat ischemic heart failure by reshaping the left ventricle of the heart, thereby enhancing its function. The company's primary clients include hospitals, cardiologists, and healthcare providers who seek advanced treatment options for heart failure patients. BioVentrix generates revenue through the sale of its medical devices and related services. The business model is centered around continuous innovation, clinical research, and strategic partnerships to expand its market presence and improve patient care.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2003
- Headquarters
- San Ramon, United States
- Employees
- 22
- Open positions
- None listed
- Dealroom signal
- 71.9/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Non-Invasive medical devices and treatments, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Apr 2023 | $49M | $194M | Richmond Brothers · Cormorant Asset Management · Squarepoint Capital · Taglich Brothers | ↗ |
| LATE VCOther financing | Dec 2020 | $41M | $163M | Undisclosed | — |
Growth signals
Latest recorded traffic for BioVentrix is 1.7K monthly website visits, up 639.1% over the last three months. BioVentrix's team grew 10% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Andera Partners
Richmond Brothers
Cormorant Asset Management- SCSquarepoint Capital
Taglich Brothers
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BioVentrix on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BioVentrix’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







